Matthew Silva to Risk Factors
This is a "connection" page, showing publications Matthew Silva has written about Risk Factors.
Connection Strength
0.079
-
Silva M, Matthews ML, Jarvis C, Nolan NM, Belliveau P, Malloy M, Gandhi P. Meta-analysis of drug-induced adverse events associated with intensive-dose statin therapy. Clin Ther. 2007 Feb; 29(2):253-60.
Score: 0.034
-
Silva MA, Donovan JL, Gandhi PJ, Volturo GA. Platelet inhibitors in non-ST-segment elevation acute coronary syndromes and percutaneous coronary intervention: glycoprotein IIb/IIIa inhibitors, clopidogrel, or both? Vasc Health Risk Manag. 2006; 2(1):39-48.
Score: 0.032
-
Malloy RJ, Kanaan AO, Silva MA, Donovan JL. Evaluation of antiplatelet agents for secondary prevention of stroke using mixed treatment comparison meta-analysis. Clin Ther. 2013 Oct; 35(10):1490-1500.e7.
Score: 0.014